Amicus Therapeutics

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Amicus Therapeutics including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Amicus Therapeutics please access flcube.comFineline Info & Tech (Flcube.com) provides you with comprehensive information about Amicus Therapeutics including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Amicus Therapeutics please access flcube.com

Biokin’s SystImmune Receives Second USD 250 Million Milestone from BMS for Iza‑Bren – Cumulative Payments Reach USD 1.3 Billion with Up to USD 7.1 Billion Still Contingent

Biokin Pharmaceutical (SHA: 688506) announced that its wholly‑owned subsidiary SystImmune has received a second milestone payment of USD 250 million from Bristol-Myers Squibb (BMS) (NYSE: BMY) under their collaboration on…

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.